US5786464C1
(en)
*
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
US6247995B1
(en)
|
1996-02-06 |
2001-06-19 |
Bruce Bryan |
Bioluminescent novelty items
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
GB9611981D0
(en)
*
|
1996-06-07 |
1996-08-07 |
Zeneca Ltd |
Enhancement of gene expression
|
AU728422B2
(en)
*
|
1996-06-21 |
2001-01-11 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6416960B1
(en)
|
1996-08-08 |
2002-07-09 |
Prolume, Ltd. |
Detection and visualization of neoplastic tissues and other tissues
|
US6124128A
(en)
*
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
US6114148C1
(en)
*
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
CA2271717A1
(fr)
|
1996-12-12 |
1998-06-18 |
Prolume, Ltd. |
Appareil permettant de detecter et d'identifier des agents infectieux et procede correspondant
|
CA2280195A1
(fr)
*
|
1997-02-07 |
1998-08-13 |
Merck & Co., Inc. |
Genes synthetiques du gag hiv
|
US6696291B2
(en)
*
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
US7105724B2
(en)
|
1997-04-04 |
2006-09-12 |
Board Of Regents Of University Of Nebraska |
Methods and materials for making and using transgenic dicamba-degrading organisms
|
CA2285676C
(fr)
|
1997-04-04 |
2011-03-08 |
Donald P. Weeks |
Methodes et materiels pour produire et utiliser des organismes transgeniques degradant dicamba
|
AUPP807899A0
(en)
*
|
1999-01-08 |
1999-02-04 |
University Of Queensland, The |
Codon utilization
|
US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
EP1025244A2
(fr)
*
|
1997-10-20 |
2000-08-09 |
Genzyme Transgenics Corporation |
SEQUENCES D'ACIDES NUCLEIQUES MSP-1 MODIFIES ET PROCEDES PERMETTANT D'ACCROITRE LES NIVEAUX D'ARNm ET L'EXPRESSION DES PROTEINES DANS LES SYSTEMES CELLULAIRES
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
WO1999042598A2
(fr)
|
1998-02-20 |
1999-08-26 |
Zeneca Limited |
Production de semences hybrides
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
US20090148906A1
(en)
*
|
1998-09-29 |
2009-06-11 |
Shire Human Genetic Therapies, Inc. A Delaware Corporation |
Optimized messenger rna
|
EP1010763A1
(fr)
*
|
1998-12-11 |
2000-06-21 |
Institut Pasteur |
Expression accrue de protéines hétérologues par des bactéries recombinantes, causée par des températures réduites et de co-expression d'ARNt rares
|
WO2000039303A2
(fr)
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Polypeptides vih env modifies
|
AU2487300A
(en)
|
1998-12-31 |
2000-07-31 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
EP1141313A2
(fr)
*
|
1998-12-31 |
2001-10-10 |
Chiron Corporation |
Expression amelioree de polypeptides hiv et production de particules de type viral
|
US7935805B1
(en)
*
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
WO2000029561A2
(fr)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Methode de production d'une construction de sequence de nucleotides a base de codons optimises, pour un vaccin genetique contre le vih, a partir d'un isolat primaire et precoce du vih, et constructions de l'enveloppe synthetique bx08
|
US20050005310A1
(en)
*
|
1999-07-12 |
2005-01-06 |
Genentech, Inc. |
Expression vectors and methods
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US20030096778A1
(en)
*
|
2002-06-13 |
2003-05-22 |
Shiver John W |
Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
|
US20040063653A1
(en)
*
|
2000-12-21 |
2004-04-01 |
Shiver John W. |
Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol
|
US6656706B2
(en)
*
|
1999-12-23 |
2003-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
|
JP2003523769A
(ja)
*
|
2000-02-23 |
2003-08-12 |
ヴァーテックス ファーマシューティカルズ (サンディエゴ)エルエルシー |
改変された蛍光タンパク質
|
US6502774B1
(en)
*
|
2000-03-08 |
2003-01-07 |
J + L Fiber Services, Inc. |
Refiner disk sensor and sensor refiner disk
|
WO2002008417A1
(fr)
*
|
2000-07-25 |
2002-01-31 |
Takeda Chemical Industries, Ltd. |
Procede de production d'une proteine de recombinaison
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
US7879540B1
(en)
*
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
WO2002020802A1
(fr)
*
|
2000-09-04 |
2002-03-14 |
Hunan Royal Biotech |
Lignee cellulaire exprimant un activateur de plasminogene tissulaire humain mutant, procede de recombinaison et procede de preparation de la proteine exprimee
|
US7122180B2
(en)
*
|
2000-10-23 |
2006-10-17 |
Children's Medical Center Corporation |
DNA vectors containing mutated HIV proviruses
|
EP1330524A2
(fr)
*
|
2000-10-30 |
2003-07-30 |
Lexicon Genetics Incorporated |
Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
EP2305699B1
(fr)
*
|
2001-06-05 |
2014-08-13 |
CureVac GmbH |
ARNm stabilisée avec un contenu augmenté en G/C et optimisée pour la translation dans ses zones codées pour la vaccination contre la trypanosomiase, la leishmaniose et la toxoplasmose
|
JP3829252B2
(ja)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
US6780974B2
(en)
*
|
2001-06-12 |
2004-08-24 |
Cellomics, Inc. |
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
|
US6943001B2
(en)
*
|
2001-08-03 |
2005-09-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
EP1578987A2
(fr)
*
|
2001-08-03 |
2005-09-28 |
Diversa Corporation |
Epoxyde-hydrolases, acides nucleiques codant ces hydrolases et procedes de fabrication et d'utilisation de celles-ci
|
WO2003020876A2
(fr)
*
|
2001-08-31 |
2003-03-13 |
Chiron Corporation |
Polynucleotides codant des polypeptides de type b du vih antigeniques, polypeptides et leurs utilisations
|
AU2002357322A1
(en)
*
|
2001-12-19 |
2003-07-09 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
ATE443133T1
(de)
|
2002-02-01 |
2009-10-15 |
Life Technologies Corp |
Oligonukleotidzusammensetzungen mit verbesserter effizienz
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
CN1659276A
(zh)
|
2002-04-19 |
2005-08-24 |
戴弗萨公司 |
磷脂酶,编码磷脂酶的核酸以及制备和应用磷脂酶的方法
|
EP2314698A1
(fr)
|
2002-06-14 |
2011-04-27 |
Verenium Corporation |
Xylanases, acides nucléiques les codant et leurs procédés de fabrication et d'utilisation
|
JP2006517090A
(ja)
*
|
2002-09-26 |
2006-07-20 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
合成遺伝子
|
AU2003275776B2
(en)
*
|
2002-11-08 |
2009-06-18 |
Jingang Medicine (Australia) Pty Ltd |
A method for optimising gene expression using synonymous codon optimisation
|
DE03779067T1
(de)
|
2002-11-12 |
2006-06-22 |
Zakrytoe Aktsionernoe Obschestvo "Evrogen" |
Fluoreszenzproteine und chromoproteine aus nicht-aequorea-hydrozoa-spezies sowie verfahren zur verwendung davon
|
US20050019925A1
(en)
*
|
2002-11-14 |
2005-01-27 |
Genentech, Inc. |
Intron fusion construct and method of using for selecting high-expressing production cell lines
|
US7413874B2
(en)
*
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
SI2311848T1
(sl)
|
2002-12-23 |
2013-11-29 |
Vical Incorporated |
Cepiva proti okuĹľbi humanega citomegalovirusa z optimizacijo kodona, ki temeljijo na polinukleotidu
|
DK1576157T3
(da)
|
2002-12-26 |
2010-11-01 |
Zakrytoe Aktsionernoe Obschest |
Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
|
DK2194133T3
(en)
|
2003-03-06 |
2016-02-29 |
Basf Enzymes Llc |
Amylases, nucleic acids encoding them, and methods of making and using the same
|
EP1601332A4
(fr)
|
2003-03-07 |
2012-05-02 |
Verenium Corp |
Hydrolases, acides nucleiques les codant, et procedes de fabrication et d'utilisation correspondants
|
MXPA05010681A
(es)
|
2003-04-04 |
2005-12-15 |
Diversa Corp |
Liasas de pectato, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
|
CA2523720A1
(fr)
*
|
2003-05-05 |
2004-11-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Gene synthetique codant pour l'antigene carcinoembryonnaire humain et son utilisation
|
EP2404929B1
(fr)
|
2003-07-02 |
2014-06-18 |
BP Corporation North America Inc. |
Glucanases, acides nucléiques les codant et leurs procédés de fabrication et d'utilisation
|
US7741089B2
(en)
|
2003-08-11 |
2010-06-22 |
Verenium Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
WO2005100387A1
(fr)
*
|
2004-04-07 |
2005-10-27 |
The University Of Chicago |
Proteines monomeres fluorescentes rouges
|
US20090069256A1
(en)
*
|
2004-06-04 |
2009-03-12 |
Smith Larry R |
Enhancing protein expression
|
PL2468853T3
(pl)
|
2004-06-16 |
2015-08-31 |
Dsm Ip Assets Bv |
Sposób enzymatycznego odbarwiania feofityny
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US7666616B2
(en)
|
2004-09-30 |
2010-02-23 |
Trustees Of Dartmouth College |
Nucleic acid sequences encoding luciferase for expression in filamentous fungi
|
US7888489B2
(en)
|
2005-01-24 |
2011-02-15 |
Dsm Ip Assets B.V. |
Method for producing a compound of interest in a filamentous fungal cell
|
WO2006099207A2
(fr)
|
2005-03-10 |
2006-09-21 |
Diversa Corporation |
Lyases, acides nucleiques codant pour celles-ci et methodes de fabrication et d'utilisation
|
EP2949756A3
(fr)
|
2005-03-15 |
2016-02-24 |
BP Corporation North America Inc. |
Cellulases, acides nucléiques les codant et leurs procédés de fabrication et d'utilisation
|
EP2264458A1
(fr)
|
2005-04-05 |
2010-12-22 |
Allergan, Inc. |
Analyses de l'activité de la toxine clostridienne
|
JP2009509970A
(ja)
*
|
2005-09-22 |
2009-03-12 |
プロサイ インコーポレイテッド |
酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
|
WO2007052102A2
(fr)
*
|
2005-11-04 |
2007-05-10 |
Evrogen, Jsc |
Proteines fluorescentes vertes modifiees et procedes d'utilisation de celles-ci
|
US7638615B1
(en)
|
2006-01-25 |
2009-12-29 |
Evrogen IP Joint Stock Company |
Fluorescent proteins and methods for using same
|
US8563703B2
(en)
|
2006-01-25 |
2013-10-22 |
Evrogen IP Joint Stock Company |
Fluorescent proteins and methods for using same
|
WO2007092314A2
(fr)
|
2006-02-02 |
2007-08-16 |
Verenium Corporation |
Estérases, acides nucléiques apparentés et procédés associés
|
US8101393B2
(en)
|
2006-02-10 |
2012-01-24 |
Bp Corporation North America Inc. |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
EP2548955A1
(fr)
|
2006-02-14 |
2013-01-23 |
Verenium Corporation |
Xylanases, acides nucléiques les codant et leurs procédés de fabrication et dýutilisation
|
AU2007223086B2
(en)
|
2006-03-07 |
2013-09-26 |
Basf Enzymes Llc |
Aldolases, nucleic acids encoding them and methods for making and using them
|
US8043837B2
(en)
|
2006-03-07 |
2011-10-25 |
Cargill, Incorporated |
Aldolases, nucleic acids encoding them and methods for making and using them
|
US7855326B2
(en)
|
2006-06-06 |
2010-12-21 |
Monsanto Technology Llc |
Methods for weed control using plants having dicamba-degrading enzymatic activity
|
JP5250850B2
(ja)
|
2006-06-29 |
2013-07-31 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
改善されたポリペプチド発現を達成する方法
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
BRPI0714876B1
(pt)
|
2006-08-04 |
2022-04-19 |
Verenium Corporation |
Ácido nucleico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula bacteriana, fúngica ou de levedura transformada, polipeptídeo isolado, sintético ou recombinante, composição, bem como métodos de produção e de usos dos mesmos
|
MX2009003034A
(es)
|
2006-09-21 |
2009-11-18 |
Verenium Corp |
Fosfolipasas, acidos nucleicos que las codifican, y metodos de hacerlas y usarlas.
|
CA2663819C
(fr)
|
2006-09-21 |
2019-04-30 |
Verenium Corporation |
Phytases, acides nucleiques les codant et leurs procedes de production et d'utilisation
|
AR063316A1
(es)
|
2006-10-16 |
2009-01-21 |
Monsanto Technology Llc |
Metodos y composiciones para mejorar el estado sanitario de plantas
|
DK2069490T4
(en)
|
2006-12-21 |
2018-04-23 |
Syngenta Participations Ag |
Amylases and Glucoamylases, Nucleic Acids Encoding Them, and Methods of Preparation and Use thereof
|
CN104212822A
(zh)
|
2007-01-30 |
2014-12-17 |
Bp法人北美有限公司 |
用于处理木质纤维素的酶、编码它们的核酸及其制备和应用方法
|
US7838729B2
(en)
|
2007-02-26 |
2010-11-23 |
Monsanto Technology Llc |
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
|
US9043994B2
(en)
*
|
2007-03-13 |
2015-06-02 |
Massachusetts Institute Of Technology |
Cre-lox based gene knockdown constructs and methods of use thereof
|
US20080248511A1
(en)
*
|
2007-03-26 |
2008-10-09 |
Promega Corporation |
Methods to quench light from optical reactions
|
WO2009045627A2
(fr)
|
2007-10-03 |
2009-04-09 |
Verenium Corporation |
Xylanases, acides nucléiques codant pour elles et leurs méthodes d'obtention et d'utilisation
|
JP5543921B2
(ja)
*
|
2007-10-15 |
2014-07-09 |
コリドン ピーティーワイ リミテッド |
免疫応答をモジュレートするための発現系
|
WO2009059305A2
(fr)
*
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Protéines fluorescentes rouges avec expression bactérienne amplifiée, luminosité accrue et agrégation réduite
|
EP2238242B9
(fr)
|
2008-01-03 |
2015-06-10 |
BASF Enzymes LLC |
Transférases et oxydoréductases, acides nucléiques codant pour celles-ci, et leurs procédés de fabrication et d'utilisation
|
DK2238261T3
(da)
|
2008-01-03 |
2014-02-10 |
Verenium Corp |
Isomeraser, nukleinsyrer der koder for dem og fremgangsmåder til fremstilling og anvendelse deraf
|
US8126653B2
(en)
*
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
US7561972B1
(en)
|
2008-06-06 |
2009-07-14 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
US8401798B2
(en)
*
|
2008-06-06 |
2013-03-19 |
Dna Twopointo, Inc. |
Systems and methods for constructing frequency lookup tables for expression systems
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
JP5304275B2
(ja)
*
|
2009-01-29 |
2013-10-02 |
Jnc株式会社 |
アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
|
CN106011159A
(zh)
|
2009-05-21 |
2016-10-12 |
巴斯夫酶有限责任公司 |
肌醇六磷酸酶、编码它们的核酸及制备和使用它们的方法
|
EP2462237B1
(fr)
|
2009-08-06 |
2015-12-23 |
Cmc Icos Biologics, Inc. |
Procédés d'amélioration de l'expression de protéine recombinante
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
KR20130028055A
(ko)
|
2010-01-28 |
2013-03-18 |
글락소 그룹 리미티드 |
Cd 127 결합 단백질
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
UY33421A
(es)
|
2010-06-03 |
2011-12-30 |
Glaxo Wellcome House |
Proteinas de union al antígeno humanizados
|
JP5883443B2
(ja)
|
2010-07-22 |
2016-03-15 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規の抗原結合タンパク質
|
JP6224077B2
(ja)
|
2012-04-17 |
2017-11-01 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
改変された核酸を用いてポリペプチドを発現させるための方法
|
WO2013166099A1
(fr)
|
2012-05-01 |
2013-11-07 |
Glaxosmithkline Llc |
Nouveaux anticorps
|
PT2850106T
(pt)
|
2012-05-18 |
2022-07-18 |
Aptevo Res & Development Llc |
Imunofusão biespecífica (bif) de scfv de ligação a cd123 e cd3
|
BR112014031526A2
(pt)
|
2012-06-19 |
2017-08-01 |
Dsm Ip Assets Bv |
promotores para expressar um gene em uma célula
|
DK3041507T3
(da)
|
2013-08-26 |
2021-07-26 |
Biontech Res And Development Inc |
Nukleinsyrer, der koder for humane antistoffer mod sialyl-lewis a
|
KR102614642B1
(ko)
|
2014-06-04 |
2023-12-19 |
바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 |
강글리오사이드 gd2에 대한 사람 단클론 항체
|
WO2016059602A2
(fr)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Méthodes de traitement du cancer et compositions associées
|
US9920102B2
(en)
|
2015-05-15 |
2018-03-20 |
Albert Einstein College Of Medicine, Inc. |
Fusion tags for protein expression
|
EP3347486A4
(fr)
|
2015-09-09 |
2019-06-19 |
The Trustees of Columbia University in the City of New York |
Réduction du fragment c99 de l'app localisé sur la membrane er-mam et procédés de traitement de la maladie d'alzheimer
|
US11707522B2
(en)
|
2017-10-13 |
2023-07-25 |
Boehringer Ingelheim International Gmbh |
Human antibodies to Tn antigen
|
RU2730038C2
(ru)
|
2018-06-28 |
2020-08-14 |
Общество с ограниченной ответственностью "ПЛАНТА" |
Ферменты биосинтеза люциферина и их применение
|
MX2021015193A
(es)
|
2019-06-28 |
2022-01-18 |
Hoffmann La Roche |
Metodo para la produccion de un anticuerpo.
|
US20230312743A1
(en)
|
2021-11-19 |
2023-10-05 |
Mirobio Limited |
Engineered pd-1 antibodies and uses thereof
|
WO2023196866A1
(fr)
|
2022-04-06 |
2023-10-12 |
Mirobio Limited |
Anticorps cd200r modifiés et leurs utilisations
|